Brought to you by 
Series F brings in $30mm for Glaukos
15 Feb 2013
Executive Summary
Meritech Capital Partners has led ophthalmic device firm Glaukos Corp.’s $30mm Series F venture round. Existing backers including Versant Ventures, Domain Associates, Montreux Equity Partners, InterWest Partners, Frazier Healthcare, OrbiMed Advisors, and Gund Investment Corp. also participated. Glaukos will use the money to fund the US commercial launch of its iStent trabecular micro-bypass device, which was approved in June 2012 for use during micro-invasive glaucoma surgery, as well as for pivotal registration studies of the next-generation inject and iStent supra suprachoroidal implant.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series F brings in $30mm for Glaukos
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice